NCT05135390View on ClinicalTrials.gov

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus

PHASE3CompletedINTERVENTIONAL
Enrollment

545

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

July 27, 2023

Study Completion Date

June 6, 2024

Conditions
PruritusHemodialysis Patients with Moderate-to-Severe Pruritus
Interventions
DRUG

HSK21542

three times per week

DRUG

Placebo

three times per week

Trial Locations (2)

Unknown

Zhong Da Hospital Southeast University, Nanjing

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY